Humana faces significant challenges with rising denial rates and customer disenrollment, which have led to a sharp decline in stock value and profitability. Medicare Advantage's struggles, including ...

The healthcare sector is a haven to trade amid market volatility, with the Healthcare sector ETF down only 3.3% YTD compared to the S&P 500's 15% decline. Humana's stock has shown resilience, boosted ...

In 2022, more Medicare Advantage plans will offer nonmedical supplemental benefits that address various social determinants of health such as meals, nutrition, transportation and in-home support ...

Humana Inc. (NYSE:HUM) on Wednesday posted a first-quarter adjusted EPS of $11.58, up from $7.23 a year ago, beating the consensus of $10.07. Humana sales increased from $29.6 billion to $32.11 ...